These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9559600)

  • 1. Reversal of late septic shock with supraphysiologic doses of hydrocortisone.
    Bollaert PE; Charpentier C; Levy B; Debouverie M; Audibert G; Larcan A
    Crit Care Med; 1998 Apr; 26(4):645-50. PubMed ID: 9559600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
    Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
    JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock.
    Oppert M; Schindler R; Husung C; Offermann K; Gräf KJ; Boenisch O; Barckow D; Frei U; Eckardt KU
    Crit Care Med; 2005 Nov; 33(11):2457-64. PubMed ID: 16276166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.
    Annane D; Sébille V; Bellissant E;
    Crit Care Med; 2006 Jan; 34(1):22-30. PubMed ID: 16374152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
    Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
    JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock.
    Peake SL; Moran JL; Leppard PI
    Crit Care Med; 1996 Aug; 24(8):1302-10. PubMed ID: 8706483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
    Heming N; Renault A; Kuperminc E; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Leone M; Timsit JF; Misset B; Benali MA; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Bounab R; Maxime V; Moine P; Bellissant E; Annane D; ;
    Lancet Respir Med; 2024 May; 12(5):366-374. PubMed ID: 38310918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions.
    Kaufmann I; Briegel J; Schliephake F; Hoelzl A; Chouker A; Hummel T; Schelling G; Thiel M
    Intensive Care Med; 2008 Feb; 34(2):344-9. PubMed ID: 17906853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.
    Arabi YM; Aljumah A; Dabbagh O; Tamim HM; Rishu AH; Al-Abdulkareem A; Knawy BA; Hajeer AH; Tamimi W; Cherfan A
    CMAJ; 2010 Dec; 182(18):1971-7. PubMed ID: 21059778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days.
    Huh JW; Choi HS; Lim CM; Koh Y; Oh YM; Shim TS; Lee SD; Kim WS; Kim DS; Hong SB
    Respirology; 2011 Oct; 16(7):1088-95. PubMed ID: 21726354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock.
    Oppert M; Reinicke A; Gräf KJ; Barckow D; Frei U; Eckardt KU
    Intensive Care Med; 2000 Dec; 26(12):1747-55. PubMed ID: 11271081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
    Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
    Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
    Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
    N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.
    Lyu QQ; Chen QH; Zheng RQ; Yu JQ; Gu XH
    J Intensive Care Med; 2020 Oct; 35(10):971-983. PubMed ID: 30270720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
    Valoor HT; Singhi S; Jayashree M
    Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrocortisone therapy for patients with septic shock.
    Sprung CL; Annane D; Keh D; Moreno R; Singer M; Freivogel K; Weiss YG; Benbenishty J; Kalenka A; Forst H; Laterre PF; Reinhart K; Cuthbertson BH; Payen D; Briegel J;
    N Engl J Med; 2008 Jan; 358(2):111-24. PubMed ID: 18184957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
    Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
    N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.